Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Karolina Hurdalkova"'
Autor:
Kristian Brat, Monika Bratova, Jana Skrickova, Magda Barinova, Karolina Hurdalkova, Milos Pesek, Libor Havel, Leona Koubkova, Michal Hrnciarik, Jana Krejci, Ondrej Fischer, Milada Zemanova, Helena Coupkova, Martin Svaton
Publikováno v:
Thoracic Cancer, Vol 11, Iss 11, Pp 3346-3356 (2020)
Background Data regarding real‐life effectiveness of any treatment may improve clinical decision‐making. The aim of this study was to evaluate real‐life effectiveness of tyrosin‐kinase inhibitors, bevacizumab and pemetrexed as first‐line tr
Externí odkaz:
https://doaj.org/article/cbc351e845594ab6848729e0cc8a090b
Autor:
Leona Koubková, Monika Bratová, Kristián Brat, Martin Svaton, Marie Drosslerova, Jana Krejčí, Juraj Kultan, Magda Barinova, Matyas Wanke, Karolina Hurdalkova
Publikováno v:
Journal of Adolescent and Young Adult Oncology. 11:451-458
Purpose: Aim was to analyze demographic and tumor characteristics, treatment, and survival of patients with lung cancer younger than 40 years of age (U40) compared to older subgroups (41–70 and >70...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63b988255245248cca1d50d616c398a2
https://doi.org/10.1089/jayao.2021.0069
https://doi.org/10.1089/jayao.2021.0069
Prognostic Value ofEGFRExon-20 Insertions in Czech Patients With Advanced Non-small Cell Lung Cancer
Autor:
Marketa Cernovska, Leona Koubková, Kristina Sandstrom, Jana Krejčí, Martin Svaton, Monika Bratová, Jiri Blazek, Jana Skrickova, P. Opálka, Helena Čoupková, Michal Hrnčiarik, Ondrej Fischer, Karolina Hurdalkova, Daniel Dolezal, Tana Tuzova, Magda Barinova, Milada Zemanova, Péter Kunovszki, Lubos Holubec, Miloš Pešek, P. Mahadevia
Publikováno v:
Anticancer Research. 41:5625-5634
Background/aim Per literature, patients with epidermal growth factor receptor (EGFR) exon-20 insertions respond poorly to tyrosine kinase inhibitors (TKIs). This study analyzed real-world data to examine the prognostic and predictive value of these m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aba859470439e22e1b459a0e725153a0
https://doi.org/10.21873/anticanres.15378
https://doi.org/10.21873/anticanres.15378
Autor:
Magda Barinova, Jana Skrickova, P. Opálka, Miloš Pešek, M. Černovská, Martin Safanda, Karolina Hurdalkova, Helena Coupkova, Martin Svaton, Daniel Krejci, Milada Zemanova, Monika Bratová, Michal Hrnčiarik, Daniel Dolezal, J. Krejčí, Petra Zemanova, Leona Koubková, Juraj Kultan, Ondrej Fischer
Publikováno v:
Anticancer Research. 41:2597-2603
Background/aim Platinum-based chemotherapy with pemetrexed or paclitaxel/bevacizumab are regimens used in combination with checkpoint inhibitors in non-squamous non-small cell lung cancer (NSCLC) treatment. We conducted a real-world study to compare
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::057bcac6de29fe9f3a3ce1185eafb469
https://doi.org/10.21873/anticanres.15039
https://doi.org/10.21873/anticanres.15039
Autor:
Josef Vodicka, Gabriela Krakorova, Jiri Blazek, Zuzana Teufelova, Magda Barinova, Karolina Hurdalkova, Marcela Buresova, Martin Svaton, Ondrej Topolcan, Miloš Pešek
Publikováno v:
Anticancer Research. 41:2053-2058
Aim To investigate potential associations between selected oncomarkers [carcinoembryonic antigen (CEA), C-terminus of cytokeratin 19 (CYFRA 21-1, CYFRA), and squamous cell carcinoma antigen (SCC)] and outcomes in patients with NSCLC treated with beva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abaeb8c40a359ee1d28ed72be3c79e05
https://doi.org/10.21873/anticanres.14974
https://doi.org/10.21873/anticanres.14974
Autor:
Monika Bratová, Daniel Dolezal, Michal Hrnčiarik, Marketa Cernovska, Magda Barinova, Tana Tuzova, Milada Zemanova, Martin Svaton, Ondrej Fischer, Jana Krejčí, Helena Čoupková, Jana Skrickova, Karolina Hurdalkova, Bedrich Porzer, Leona Koubková
Publikováno v:
Anticancer Research. 41:2059-2065
Background/Aim: We investigated efficacy differences for afatinib versus gefitinib in non-small-cell lung cancer (NSCLC) according to epidermal growth factor receptor (EGFR) mutations. Patients and Methods: We retrospectively analysed data for 343 pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4331a04cd5136e45149536b6038b4c3d
https://doi.org/10.21873/anticanres.14975
https://doi.org/10.21873/anticanres.14975
Autor:
Marcela Buresova, Martin Svaton, Magda Barinova, Josef Vodicka, Zuzana Teufelova, Gabriela Krakorova, Miloš Pešek, Jiri Blazek, Karolina Hurdalkova
Publikováno v:
Journal of Cancer
Purpose: To investigate potential associations between selected laboratory markers (CRP, LDH, albumin, sodium, hemoglobin, neutrophils, and neutrophils/lymphocytes ratio [NLR]) and outcomes in patients with non-small cell lung cancer (NSCLC) treated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f8f515d1b6743e0f55b9cc0839e9f05
https://doi.org/10.7150/jca.58851
https://doi.org/10.7150/jca.58851
Autor:
Martin Svaton, Kristián Brat, Libor Havel, Magda Barinova, Leona Koubková, Helena Čoupková, Jana Skrickova, Ondrej Fischer, Michal Hrnčiarik, Karolina Hurdalkova, Milada Zemanova, Jana Krejčí, Monika Bratová, Miloš Pešek
Publikováno v:
Thoracic Cancer, Vol 11, Iss 11, Pp 3346-3356 (2020)
Thoracic Cancer
Thoracic Cancer
Background Data regarding real‐life effectiveness of any treatment may improve clinical decision‐making. The aim of this study was to evaluate real‐life effectiveness of tyrosin‐kinase inhibitors, bevacizumab and pemetrexed as first‐line tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1621c2d5fc04c794121b2b22badc5ff
https://doaj.org/article/cbc351e845594ab6848729e0cc8a090b
https://doaj.org/article/cbc351e845594ab6848729e0cc8a090b
Autor:
Magda Barinova, Bohuslav Melichar, Karolina Hurdalkova, Martin Svaton, Jiri Blazek, Lenka Jakubíková, M. Černovská, Michal Jirousek, Daniel Krejci, Jana Skrickova, Milada Zemanova, J. Krejčí, Petra Zemanova, Michal Hrnčiarik, Ondrej Bilek, Ondrej Fischer, Juraj Kultan
Publikováno v:
Anticancer Research. 40:2209-2217
To investigate potential association between administration of corticosteroids, antibiotics, probiotics, proton pump inhibitors, non-steroidal anti-inflammatory drugs (NSAID), statins and metformin and outcome in patients with non-small cell lung can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4470fb7f205d242846a16e4aa39f0ebb
https://doi.org/10.21873/anticanres.14182
https://doi.org/10.21873/anticanres.14182
Autor:
Martin Svaton, Monika Bratová, Matyas Wanke, Kristián Brat, Karolina Hurdalkova, Marie Drosslerova, Juraj Kultan
Publikováno v:
Lung cancer.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8591d848327f1f0374df8eaf240a71a6
https://doi.org/10.1183/13993003.congress-2021.pa3851
https://doi.org/10.1183/13993003.congress-2021.pa3851